plumbagin has been researched along with Osteoporosis, Postmenopausal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, R; Lei, W; Liu, X; Shen, G; Yao, Z | 1 |
1 other study(ies) available for plumbagin and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Plumbagin is a NF-κB-inducing kinase inhibitor with dual anabolic and antiresorptive effects that prevents menopausal-related osteoporosis in mice.
Topics: Animals; Bone Density Conservation Agents; Female; Humans; Mice; Naphthoquinones; NF-kappa B; NF-kappaB-Inducing Kinase; Osteoclasts; Osteoporosis, Postmenopausal; Protein Serine-Threonine Kinases | 2022 |